173 related articles for article (PubMed ID: 12112362)
1. Ceramide levels are inversely associated with malignant progression of human glial tumors.
Riboni L; Campanella R; Bassi R; Villani R; Gaini SM; Martinelli-Boneschi F; Viani P; Tettamanti G
Glia; 2002 Aug; 39(2):105-13. PubMed ID: 12112362
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
3. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
4. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
6. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
7. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
8. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
[TBL] [Abstract][Full Text] [Related]
9. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
10. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
14. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
Nafe R; Van de Nes J; Yan B; Schlote W
Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
[TBL] [Abstract][Full Text] [Related]
15. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
[TBL] [Abstract][Full Text] [Related]
16. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
17. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
18. High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression.
Rushing EJ; Sandberg GD; Horkayne-Szakaly I
Int J Surg Pathol; 2010 Aug; 18(4):255-9. PubMed ID: 19578047
[TBL] [Abstract][Full Text] [Related]
19. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues.
Zengin E; Atukeren P; Kokoglu E; Gumustas MK; Zengin U
Clin Neurol Neurosurg; 2009 May; 111(4):345-51. PubMed ID: 19117666
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside shedding and changes in ceramide biosynthesis in human ovarian tumors.
Dyatlovitskaya EV; Andreasyan GO; Malykh YaN ; Rylova SN; Somova OG
Biochemistry (Mosc); 1997 May; 62(5):557-61. PubMed ID: 9275295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]